News

Market Screener
marketscreener. com > news > bioxcel-therapeutics-presents-new-data-from-serenity-at-home-phase-3-trial-for-agitation-associated-ce7f5ddadb8cf723

Bio Xcel Therapeutics Presents New Data from Serenity At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia

4+ hour, 43+ min ago  (534+ words) marketscreener. com Bio Xcel Therapeutics Presents New Data from Serenity At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia Published on 05/28/2026 at 07: 51 am EDT Bio Xcel Therapeutics, Inc. announced the presentation of new positive data from the Phase…...

Symbols: btc-usd
Market Screener
marketscreener. com > news > minerva-neurosciences-olanzapine-added-to-roluperidone-in-patients-with-negative-symptoms-ns-of-ce7e51dad088fe2d

Minerva Neurosciences: Olanzapine added to Roluperidone, in patients with negative symptoms (NS) of schizophrenia

2+ mon, 1+ day ago  (566+ words) Published on 03/26/2026 at 01: 57 pm EDT "A Study of roluperidone coadministered with olanzapine in patients with negative symptoms (NS) of schizophrenia An open-label safety trial Specific Affinity for 5-HT2 A, " 2, and " 1-adrenergic receptors The behavioural pharmacology package is consistent with an antagonistic…...

Symbols: nda,fda,nerv
Market Screener
marketscreener. com > news > alzamend-neuro-initiates-phase-ii-clinical-trial-of-al001-lithium-in-brain-study-in-patients-with-ce7e5edadc8cfe2d

Alzamend Neuro initiates phase II clinical trial of AL001 "lithium in brain" study in patients with bipolar disorder in collaboration with Massachusetts General Hospital

2+ mon, 1+ week ago  (82+ words) marketscreener. com Biotechnology & Medical Research Alzamend Neuro initiates phase II clinical trial of AL001 "lithium in brain" study in patients with bipolar disorder in collaboration with Massachusetts General Hospital Published on 03/16/2026 at 08: 50 am EDT Latest news about Alzamend Neuro, Inc. Chart…...

Symbols: fda,mdd